申请人:SANOFI SA
公开号:WO2013186240A2
公开(公告)日:2013-12-19
The present invention relates to exendin-4 peptide analogues and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.